InvestorsHub Logo
Followers 5
Posts 356
Boards Moderated 0
Alias Born 03/18/2013

Re: fsulevine post# 273817

Friday, 05/15/2020 12:17:07 AM

Friday, May 15, 2020 12:17:07 AM

Post# of 424006
fsulevine-

That's just not true - Judge Du fully understood that the generics would sell under the guise of the Reduce-It indication if she invalidated the Marine obviousness patent.

What she meant by nothing changes with regards to the Reduce-it is well exactly that but she fully realized that the generics would "effectively" sell generic Vascepa under the Reduce-It label.

Unfortunately she wasn't supposed to take this end around into consideration and neither is the appellate court. Hopefully the procedure errors will be enough for the appellate court either because the judges truly believe that's the case or use the errors as an excuse to not allow the generics to steal from Amarin.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News